55 related articles for article (PubMed ID: 32296929)
1. The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers.
Compérat E; Amin MB; Epstein JI; Hansel DE; Paner G; Al-Ahmadie H; True L; Bayder D; Bivalacqua T; Brimo F; Cheng L; Cheville J; Dalbagni G; Falzarano S; Gordetsky J; Guo C; Gupta S; Hes O; Iyer G; Kaushal S; Kunju L; Magi-Galluzzi C; Matoso A; McKenney J; Netto GJ; Osunkoya AO; Pan CC; Pivovarcikova K; Raspollini MR; Reis H; Rosenberg J; Roupret M; Shah RB; Shariat SF; Trpkov K; Weyerer V; Zhou M; Reuter V
Adv Anat Pathol; 2021 Jul; 28(4):196-208. PubMed ID: 34128484
[TBL] [Abstract][Full Text] [Related]
2. What's new in WHO fifth edition - urinary tract.
Compérat E; Amin MB; Berney DM; Cree I; Menon S; Moch H; Netto GJ; Rao V; Raspollini MR; Rubin MA; Srigley JR; Tan PH; Tickoo SK; Turajlic S; Tsuzuki T
Histopathology; 2022 Oct; 81(4):439-446. PubMed ID: 35942645
[TBL] [Abstract][Full Text] [Related]
3. The Application and Pitfalls of Immunohistochemical Markers in Challenging Diagnosis of Genitourinary Pathology.
Li J; Wilkerson ML; Deng FM; Liu H
Arch Pathol Lab Med; 2024 Jan; 148(1):13-32. PubMed ID: 37074862
[TBL] [Abstract][Full Text] [Related]
4. Similarities and Differences in the 2019 ISUP and GUPS Recommendations on Prostate Cancer Grading: A Guide for Practicing Pathologists.
Smith SC; Gandhi JS; Moch H; Aron M; Compérat E; Paner GP; McKenney JK; Amin MB
Adv Anat Pathol; 2021 Jan; 28(1):1-7. PubMed ID: 33027069
[TBL] [Abstract][Full Text] [Related]
5. Morphological correlation of urinary bladder cancer molecular subtypes in radical cystectomies.
Han L; Gallan AJ; Steinberg GD; Sweis RF; Paner GP
Hum Pathol; 2020 Dec; 106():54-61. PubMed ID: 32987034
[TBL] [Abstract][Full Text] [Related]
6. Stage T1 bladder cancer: diagnostic criteria and pitfalls.
Lopez-Beltran A; Cheng L
Pathology; 2021 Jan; 53(1):67-85. PubMed ID: 33153725
[TBL] [Abstract][Full Text] [Related]
7. Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer.
Moschini M; Afferi L; Gandaglia G; D'Andrea D; Zamboni S; Di Bona C; Mordasini L; Mattei A; Baumeister P; Martini A; Burgio G; Shariat SF; Sanchez-Salas R; Cathelineau X; Stabile A; Zaffuto E; Salonia A; Colombo R; Necchi A; Montorsi F; Briganti A; Gallina A
Eur Urol Focus; 2021 Sep; 7(5):1067-1074. PubMed ID: 33020030
[TBL] [Abstract][Full Text] [Related]
8. T1 Substaging of Nonmuscle Invasive Bladder Cancer is Associated with bacillus Calmette-Guérin Failure and Improves Patient Stratification at Diagnosis.
de Jong FC; Hoedemaeker RF; Kvikstad V; Mensink JTM; de Jong JJ; Boevé ER; van der Schoot DKE; Zwarthoff EC; Boormans JL; Zuiverloon TCM
J Urol; 2021 Mar; 205(3):701-708. PubMed ID: 33191862
[TBL] [Abstract][Full Text] [Related]
9. The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer.
Hermann GG; Horn T; Steven K
J Urol; 1998 Jan; 159(1):91-4. PubMed ID: 9400444
[TBL] [Abstract][Full Text] [Related]
10. Prospective Validation of the ROL System in Substaging pT1 High-Grade Urothelial Carcinoma: Results from a Mono-Institutional Confirmatory Analysis in BCG Treated Patients.
Valeri M; Contieri R; Fasulo V; Iuzzolino M; Cieri M; Elefante GM; De Carlo C; Bressan A; Saitta C; Gobbo A; Avolio PP; Dacrema V; Lazzeri M; Taverna G; Terracciano LM; Hurle R; Colombo P
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765894
[TBL] [Abstract][Full Text] [Related]
11. News in the classification of WHO 2022 bladder tumors.
Raspollini MR; Comperat EM; Lopez-Beltran A; Montironi R; Cimadamore A; Tsuzuki T; Netto GJ
Pathologica; 2022 Feb; 115(1):32-40. PubMed ID: 36704871
[TBL] [Abstract][Full Text] [Related]
12. Bladder Cancer Sample Handling and Reporting: Pathologist's Point of View.
Mazzucchelli R; Marzioni D; Tossetta G; Pepi L; Montironi R
Front Surg; 2021; 8():754741. PubMed ID: 34926567
[TBL] [Abstract][Full Text] [Related]
13. pT1 high-grade bladder cancer: histologic criteria, pitfalls in the assessment of invasion, and substaging.
Raspollini MR; Montironi R; Mazzucchelli R; Cimadamore A; Cheng L; Lopez-Beltran A
Virchows Arch; 2020 Jul; 477(1):3-16. PubMed ID: 32296929
[TBL] [Abstract][Full Text] [Related]
14. Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.
Paner GP; Montironi R; Amin MB
Adv Anat Pathol; 2017 May; 24(3):113-127. PubMed ID: 28398951
[TBL] [Abstract][Full Text] [Related]
15. Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression.
Lawless M; Gulati R; Tretiakova M
Histopathology; 2017 Sep; 71(3):406-414. PubMed ID: 28470753
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis.
Kardoust Parizi M; Enikeev D; Glybochko PV; Seebacher V; Janisch F; Fajkovic H; Chłosta PL; Shariat SF
World J Urol; 2020 Jun; 38(6):1437-1449. PubMed ID: 31493109
[TBL] [Abstract][Full Text] [Related]
17. Staging of bladder cancer.
Magers MJ; Lopez-Beltran A; Montironi R; Williamson SR; Kaimakliotis HZ; Cheng L
Histopathology; 2019 Jan; 74(1):112-134. PubMed ID: 30565300
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
